Philippe Ruminy Selected Research

Philippe Ruminy Research Topics

Disease

18	Neoplasms (Cancer) 12/2023 - 09/2008
10	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023 - 05/2015
9	Lymphoma (Lymphomas) 02/2024 - 08/2007
9	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2021 - 04/2015
3	Hodgkin Disease (Hodgkin's Disease) 10/2020 - 01/2016
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 02/2024 - 10/2015
2	T-Cell Lymphoma (Lymphoma, T Cell) 06/2023 - 01/2020
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 06/2019
2	Infections 01/2021 - 01/2016
2	Adenocarcinoma of Lung 01/2021 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 03/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 06/2023
1	Breast Neoplasms (Breast Cancer) 04/2023
1	Carcinogenesis 04/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2020
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2016
1	Residual Neoplasm 01/2016
1	Hypoxia (Hypoxemia) 03/2014
1	Squamous Cell Carcinoma of Head and Neck 03/2014

Drug/Important Bio-Agent (IBA)

7	DNA (Deoxyribonucleic Acid)IBA 10/2020 - 01/2016
6	Cell-Free Nucleic AcidsIBA 10/2020 - 07/2015
4	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2022 - 04/2015
3	RNA (Ribonucleic Acid)IBA 02/2024 - 01/2021
3	NucleotidesIBA 01/2022 - 01/2020
2	ParaffinIBA 11/2023 - 01/2022
2	Formaldehyde (Formol)FDA Link 11/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 12/2022 - 01/2016
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 12/2022 - 01/2017
2	Phosphotransferases (Kinase)IBA 11/2021 - 01/2018
2	Rituximab (Mabthera)FDA Link 10/2021 - 01/2021
2	Lenalidomide (CC 5013)FDA Link 10/2021 - 01/2019
2	Anaplastic Lymphoma KinaseIBA 01/2021 - 01/2018
2	obinutuzumabIBA 01/2021 - 01/2019
2	ChromatinIBA 01/2018 - 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2024
1	Immunoglobulins (Immunoglobulin)IBA 02/2024
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2023
1	belinostatIBA 06/2023
1	Circular RNAIBA 04/2023
1	Complementary DNA (cDNA)IBA 12/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	TropomyosinIBA 11/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 10/2020
1	ErbB Receptors (EGF Receptor)IBA 01/2020
1	epidermal growth factor receptor VIIIIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 06/2019
1	Cyclin D1IBA 01/2019
1	CyclinsIBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	CohesinsIBA 01/2018
1	Indicators and Reagents (Reagents)IBA 11/2017
1	AntigensIBA 01/2017
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Exportin 1 ProteinIBA 01/2016
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	Immunoglobulin M (IgM)IBA 10/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 10/2015
1	Enhancer of Zeste Homolog 2 ProteinIBA 06/2015
1	IgA receptor (protein B)IBA 12/2014
1	Glucose (Dextrose)FDA LinkGeneric 03/2014
1	Lactic Acid (Lactate)FDA LinkGeneric 03/2014
1	Cytidine DeaminaseIBA 09/2008
1	RNA Splice SitesIBA 08/2007

Therapy/Procedure

6	Ligation 01/2022 - 04/2015
4	Therapeutics 06/2023 - 04/2015
2	Drug Therapy (Chemotherapy) 12/2023 - 06/2019
1	Stem Cell Transplantation 06/2023
1	Combination Drug Therapy (Combination Chemotherapy) 01/2021
1	Breast Implants (Breast Implant) 01/2020
1	Precision Medicine 05/2015